Abstract:Normal vasculature is quiescent in healthy adults with each endothelial cell dividing once every 10 years. But, angiogenesis is crucial for the growth and metastasis of breast cancer, and has been targeted for developing therapeutics. The current treatments are effective in only a small percentage of the total patient population. In addition, they are expensive, and accompanied by a host of side effects detrimental to patient9s quality of life. Our laboratory has recently established that tunicamycin (an antibiotic and a glucosamine-containing pyrimidine nucleoside) interferes with the dynamic process of asparagine-linked protein glycosylation inhibiting angiogenesis in vitro and in vivo Matrigel ™ implants. It causes cell cycle arrest in G1 and induces endoplasmic reticulum (ER) stress-mediated unfolded protein response (upr), and apoptosis by down regulated expression of Bcl-2 and cyclin D1, and upregulated expression of GRP-78/Bip and caspases3, 9 and 12. High expression of ATF6 and PERK in capillary endothelial cells indicates transcriptional and translational attenuation. Irreversibility of cellular proliferation by either IGF-1 or VEGF or inhibition of cell growth by clonogenic assay supports that tunicamycin can stand tumor microenvironment. There is down-regulation of phosphotyrosine kinase activity as well as the phosphoVEGFR1 and VEGFR2 levels. Most importantly, tunicamycin reduces the progression of a double negative (ER − /PR − /EGFR + ) grade III breast adenocarcinoma and a triple negative (ER − /PR − /EGFR − ) breast tumor xenograft in nude mice. Histopathology indicates reduced microvascular density and low tumor mitotic index along with reduced K-67 and VEGF expression. A significant reduction of N-glycan expression on the vessel wall correlates with the vessels size, and a high expression of GRP-78/Bip in CD144 positive vessels supports vessel death due to ER stress-mediated upr. WGA staining of tumor epithelia indicates loss of structural integrity with a high GRP-78/Bip expression, and has raised a question if induction of ER stress in tumor epithelia is an indirect effect of nutrient deprivation due to reduced blood flow in the absence of angiogenesis or does tunicamycin directly induce ER stress in the tumor cells. To test this hypothesis we have used a triple negative MDA-MB-231 human breast cancer cell line and cultured them with tunicamycin in a custom made media. Our results show that tunicamycin inhibits cell proliferation in a dose- and time-dependent manner as well as the colony formation. Expression of cyclin D1, wild type p53, phopspho p53(ser 392), Bcl-2 and caspase-3 supports cell cycle arrest followed by induction of apoptosis. High expression of GRP-78 and PERK/phosphoPERK concludes that tunicamycin can induce ER stress-mediated upr in MDA-MB-231 breast cancer cells. Supported in part by grants from Susan G. Komen for the Cure (BCTR06582) and NIH/NCRR/RCMI G12-RR03035 (KB) Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2313. doi:1538-7445.AM2012-2313

Endoplasmic Reticulum Stress Inhibits Cell Cycle Progression Via Induction of P27 in Melanoma Cells.

Increased Cul1 Expression Promotes Melanoma Cell Proliferation Through Regulating P27 Expression

Er Stress-Mediated Unfolded Protein Response Inhibits Angiogenesis And Breast Tumor Growth

[Role of dysregulation of Bim in resistance of melanoma cells to endoplasmic reticulum stress-induced apoptosis].

miR-217 regulates normal and tumor cell fate following induction of Endoplasmic Reticulum Stress

Endoplasmic Reticulum Stress Regulates Tumor Growth and Anti-Tumor Immunity: a Promising Opportunity for Cancer Immunotherapy

Bap1 Regulates Cell Cycle Progression Through E2f1 Target Genes and Mediates Transcriptional Silencing Via H2a Monoubiquitination in Uveal Melanoma Cells

Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130

SKP2 Targeted Inhibition Suppresses Human Uveal Melanoma Progression by Blocking Ubiquitylation of P27.

Upregulated Expression of Grp78 Supports Er Stress-Induced Apoptosis in Tunicamycin Treated Triple Negative Breast Tumor

Improvement of chemotherapeutic drug efficacy by endoplasmic reticulum stress

Tazarotene-induced Gene 1 Induces Melanoma Cell Death by Triggering Endoplasmic Reticulum Stress Response

The Tumor Suppressor TPD52‐Governed Endoplasmic Reticulum Stress is Modulated by APCCdc20

Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway

Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells

Endoplasmic Reticulum Stress Activates Telomerase

Endoplasmic Reticulum Stress Promotes Autophagy and Apoptosis and Reduces Chemotherapy Resistance in Mutant p53 Lung Cancer Cells

Knockdown Of Crm1 Inhibits The Nuclear Export Of P27(Kip1) Phosphorylated At Serine 10 And Plays A Role In The Pathogenesis Of Epithelial Ovarian Cancer

Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells

Curcumin induces cell death of human papillary thyroid carcinoma BCPAP cells through endoplasmic reticulum stress

Downregulation of Nuclear Protein-1 Induces Cell Cycle Arrest in G0/G1 Phase in Glioma Cells in Vivo and in Vitro Via P27